Enzychem Lifesciences Corporation (KOSDAQ:183490)
1,069.00
-40.00 (-3.61%)
Apr 2, 2025, 3:30 PM KST
Enzychem Lifesciences Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | -22,107 | -9,326 | -25,093 | -27,865 | -17,507 | Upgrade
|
Depreciation & Amortization | 3,458 | 3,512 | 2,389 | 2,111 | 2,036 | Upgrade
|
Loss (Gain) From Sale of Assets | 1.34 | 20 | 10.98 | 13.27 | - | Upgrade
|
Asset Writedown & Restructuring Costs | 145.56 | 32.74 | 4,692 | -16.05 | 60.09 | Upgrade
|
Loss (Gain) From Sale of Investments | 2,010 | -3.65 | -3.57 | -4.39 | 251.47 | Upgrade
|
Loss (Gain) on Equity Investments | 2,176 | -26.87 | 13.64 | 445.14 | 378.53 | Upgrade
|
Stock-Based Compensation | - | 54.33 | -306.12 | 711.91 | 50.35 | Upgrade
|
Provision & Write-off of Bad Debts | -85.85 | 199.23 | -111.75 | 16.95 | -131.08 | Upgrade
|
Other Operating Activities | 11,073 | 1,785 | 7,300 | 7,746 | -1,303 | Upgrade
|
Change in Accounts Receivable | 3,732 | -4,202 | -1,046 | -1,037 | 4,572 | Upgrade
|
Change in Inventory | 2,832 | -4,574 | -1,439 | 822.73 | -1,331 | Upgrade
|
Change in Accounts Payable | -3,979 | 4,392 | -333.72 | 1,703 | -1,871 | Upgrade
|
Change in Unearned Revenue | - | 1.94 | 110.39 | 180.05 | 292.13 | Upgrade
|
Change in Other Net Operating Assets | 168.7 | -2,122 | -501.84 | -3,417 | 481.93 | Upgrade
|
Operating Cash Flow | -573.93 | -10,258 | -14,320 | -18,589 | -14,021 | Upgrade
|
Capital Expenditures | -323.82 | -2,248 | -7,957 | -5,818 | -2,836 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | 1.34 | 7.5 | - | Upgrade
|
Cash Acquisitions | - | -577.53 | - | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -6.7 | -54.19 | -55.45 | -64.45 | -260.87 | Upgrade
|
Investment in Securities | 15,363 | 62,350 | -93,370 | -3,665 | -42,569 | Upgrade
|
Other Investing Activities | -1,962 | -139.25 | -7,429 | -240.88 | 183.1 | Upgrade
|
Investing Cash Flow | 7,359 | 53,562 | -109,233 | -9,729 | -45,242 | Upgrade
|
Short-Term Debt Issued | 3,983 | 2,554 | 45,671 | 7,140 | 6,694 | Upgrade
|
Long-Term Debt Issued | - | 1,000 | - | - | 57,096 | Upgrade
|
Total Debt Issued | 3,983 | 3,554 | 45,671 | 7,140 | 63,790 | Upgrade
|
Short-Term Debt Repaid | -2,853 | -25,640 | -26,991 | -6,420 | -4,628 | Upgrade
|
Long-Term Debt Repaid | -2,446 | -12,666 | -43,889 | -1,559 | -537.46 | Upgrade
|
Total Debt Repaid | -5,299 | -38,306 | -70,880 | -7,978 | -5,165 | Upgrade
|
Net Debt Issued (Repaid) | -1,316 | -34,752 | -25,210 | -838.54 | 58,625 | Upgrade
|
Issuance of Common Stock | - | - | 153,713 | 30,102 | 224.89 | Upgrade
|
Repurchase of Common Stock | -10,822 | - | - | - | - | Upgrade
|
Other Financing Activities | -0 | -1.2 | -0 | 0 | -22.97 | Upgrade
|
Financing Cash Flow | -12,138 | -35,503 | 128,504 | 29,263 | 58,827 | Upgrade
|
Foreign Exchange Rate Adjustments | 186.64 | -13.79 | -83.11 | 12.7 | -12.06 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | 0 | - | - | 0 | Upgrade
|
Net Cash Flow | -5,166 | 7,787 | 4,868 | 958.31 | -448.3 | Upgrade
|
Free Cash Flow | -897.74 | -12,506 | -22,277 | -24,407 | -16,857 | Upgrade
|
Free Cash Flow Margin | -1.16% | -16.45% | -83.63% | -106.23% | -65.29% | Upgrade
|
Free Cash Flow Per Share | -10.96 | -147.50 | -282.63 | -483.37 | -346.96 | Upgrade
|
Cash Interest Paid | 240.83 | 478.22 | -174.26 | 366.93 | 231.37 | Upgrade
|
Cash Income Tax Paid | -317.1 | 867.51 | 76.33 | 11.49 | 41.13 | Upgrade
|
Levered Free Cash Flow | -4,554 | -13,645 | -32,617 | -22,543 | -11,130 | Upgrade
|
Unlevered Free Cash Flow | -4,405 | -13,258 | -26,348 | -16,600 | -10,236 | Upgrade
|
Change in Net Working Capital | -2,703 | 5,259 | 11,561 | -142.78 | -2,767 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.